Technical Analysis for INZY - Inozyme Pharma, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 1.87% | |
Oversold Stochastic | Weakness | 1.87% | |
Outside Day | Range Expansion | 6.76% | |
Oversold Stochastic | Weakness | 6.76% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 3.99% | |
Stochastic Reached Oversold | Weakness | 3.99% | |
Inside Day | Range Contraction | 3.99% | |
Oversold Stochastic | Weakness | 3.99% |
Alert | Time |
---|---|
20 DMA Resistance | about 10 hours ago |
Up 5% | about 14 hours ago |
Rose Above 20 DMA | about 15 hours ago |
Up 3% | about 15 hours ago |
Up 2% | about 15 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/20/2024
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as in the early stages of development for calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Disease Pharmacy Molecular Biology Specialty Drugs Genetic Diseases Rare Genetic Disease Rare Genetic Diseases Recombinant Dna
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Disease Pharmacy Molecular Biology Specialty Drugs Genetic Diseases Rare Genetic Disease Rare Genetic Diseases Recombinant Dna
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.33 |
52 Week Low | 2.689 |
Average Volume | 488,974 |
200-Day Moving Average | 4.75 |
50-Day Moving Average | 5.41 |
20-Day Moving Average | 6.05 |
10-Day Moving Average | 5.96 |
Average True Range | 0.39 |
RSI (14) | 53.49 |
ADX | 23.72 |
+DI | 25.05 |
-DI | 19.69 |
Chandelier Exit (Long, 3 ATRs) | 5.85 |
Chandelier Exit (Short, 3 ATRs) | 6.61 |
Upper Bollinger Bands | 6.76 |
Lower Bollinger Band | 5.33 |
Percent B (%b) | 0.47 |
BandWidth | 23.58 |
MACD Line | 0.11 |
MACD Signal Line | 0.20 |
MACD Histogram | -0.0888 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 6.70 | ||||
Resistance 3 (R3) | 6.70 | 6.47 | 6.58 | ||
Resistance 2 (R2) | 6.47 | 6.29 | 6.47 | 6.54 | |
Resistance 1 (R1) | 6.24 | 6.18 | 6.35 | 6.23 | 6.50 |
Pivot Point | 6.01 | 6.01 | 6.06 | 6.00 | 6.01 |
Support 1 (S1) | 5.77 | 5.83 | 5.89 | 5.77 | 5.50 |
Support 2 (S2) | 5.54 | 5.72 | 5.54 | 5.46 | |
Support 3 (S3) | 5.31 | 5.54 | 5.42 | ||
Support 4 (S4) | 5.30 |